L
7.19
0.01 (0.14%)
| Previous Close | 7.18 |
| Open | 7.20 |
| Volume | 1,073,906 |
| Avg. Volume (3M) | 1,546,747 |
| Market Cap | 2,751,181,568 |
| Price / Earnings (Forward) | 227.27 |
| Price / Sales | 2.21 |
| Price / Book | 1.88 |
| 52 Weeks Range | |
| Earnings Date | 7 Nov 2024 |
| Profit Margin | -7.90% |
| Operating Margin (TTM) | 0.13% |
| Diluted EPS (TTM) | -0.260 |
| Quarterly Revenue Growth (YOY) | 19.00% |
| Total Debt/Equity (MRQ) | 34.07% |
| Current Ratio (MRQ) | 1.32 |
| Operating Cash Flow (TTM) | 61.74 M |
| Levered Free Cash Flow (TTM) | 96.30 M |
| Return on Assets (TTM) | -1.55% |
| Return on Equity (TTM) | -6.59% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | LifeStance Health Group, Inc. | Bullish | Bullish |
AIStockmoo Score
0.6
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -0.5 |
| Average | 0.63 |
|
LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 11.11% |
| % Held by Institutions | 91.38% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Summit Partners L P | 30 Sep 2024 | 41,932,358 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 10.00 (Goldman Sachs, 39.08%) | Buy |
| Median | 8.50 (18.22%) | |
| Low | 7.00 (Barclays, -2.64%) | Sell |
| Average | 8.50 (18.22%) | |
| Total | 1 Buy, 1 Sell | |
| Avg. Price @ Call | 7.57 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Goldman Sachs | 16 Dec 2024 | 10.00 (39.08%) | Buy | 7.75 |
| Barclays | 11 Nov 2024 | 7.00 (-2.64%) | Sell | 7.39 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Nov 2024 | Announcement | LifeStance Reports Third Quarter 2024 Results |
| 17 Oct 2024 | Announcement | LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024 |
| 08 Oct 2024 | Announcement | LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |